Table 2.
Microvessel density assessment
Ref.
|
MVD assessment method
|
Antibody
|
Magnification used
|
Spots examined
|
Blinded reading
|
Observers
|
Separate count for intra/peritumoral vessels
|
MVD cut off
|
Chen et al[22] | Light microscopy, immunohistochemistry | CD31 | 10X; 20X; 100X | 3 | N/A | N/A | N/A | 15/HPF |
Imamura et al[8] | Light microscopy, immunohistochemistry, slight modification of Horak et al technique | CD31 | 40X; 200X | 10 | Yes | 2 | N/A | 7/0.95 mm² |
Takahashi et al[23] | Light microscopy, immunohistochemistry | CD31 | 40X; 100X; 400X | 3 | N/A | N/A | N/A | 19/HPF |
Waengertner et al[24] | Light microscopy, immunohistochemistry, modified Chalkley method | CD31 | 200X | 3 to 5 | N/A | N/A | N/A | 6 vessels |
Wang et al[9] | Light microscopy, immunohistochemistry | CD31 | 200X | 4 | Yes | 2 | N/A | 10.54/200HPF |
Zhao et al[25] | Light microscopy, immunohistochemistry, Weidner technique | CD34 | 100X; 200X | 5 | N/A | N/A | N/A | N/A |
MVD: Microvessel density; N/A: Not applicable.